ArticleEuropean urology2020

Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities.

Grace Lu-Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.